Prosecution Insights
Last updated: August 17, 2026

Examiner: DICKINSON, PAUL W

Tech Center 1600 • Art Units: 1614 1618

This examiner grants 63% of resolved cases

Performance Statistics

62.8%
Allow Rate
+2.8% vs TC avg
1,079
Total Applications
+9.9%
Interview Lift
1201
Avg Prosecution Days
Based on 1039 resolved cases, 2023–2026

Rejection Statute Breakdown

1.5%
§101 Eligibility
17.8%
§102 Novelty
42.3%
§103 Obviousness
26.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18794911 COMPOSITIONS AND METHODS OF MAKING POLYMERIZING NUCLEIC ACIDS Non-Final OA The Regents of the University of California
17785765 SEQUENTIAL TARGETING IN CROSSLINKING NANO-THERANOSTICS FOR TREATING BRAIN TUMORS Non-Final OA The Regents of the University of California
18774558 HIGHLY LUMINESCENT BIODEGRADABLE UPCONVERSION NANOPROBE HAVING LONG DECOMPOSITION TIME Non-Final OA Research & Business Foundation SUNGKYUNKWAN UNIVERSITY
17906913 CELL ACTIVATABLE IRON CHELATORS Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
17827479 BRANCHED DISCRETE PEG CONSTRUCTS Final Rejection UNIVERSITY OF WASHINGTON
17825217 System, Emanation Generator, and Process for Production of High-Purity Therapeutic Radioisotopes Non-Final OA BATTELLE MEMORIAL INSTITUTE
17012614 MAGNETIC IMMUNO-PARTICLE AND USE THEREOF Non-Final OA UNIST(ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY)
17054050 BIOCOMPATIBLE COPOLYMER CONTAINING MULTIPLE ACTIVE AGENT MOLECULES Non-Final OA CIS PHARMA AG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month